Vanguard Group Inc Dexcom Inc Transaction History
Vanguard Group Inc
- $5.46 Trillion
- Q3 2024
A detailed history of Vanguard Group Inc transactions in Dexcom Inc stock. As of the latest transaction made, Vanguard Group Inc holds 47,434,801 shares of DXCM stock, worth $3.6 Billion. This represents 0.06% of its overall portfolio holdings.
Number of Shares
47,434,801
Previous 46,513,184
1.98%
Holding current value
$3.6 Billion
Previous $5.27 Billion
39.72%
% of portfolio
0.06%
Previous 0.1%
Shares
15 transactions
Others Institutions Holding DXCM
# of Institutions
1,013Shares Held
351MCall Options Held
5.51MPut Options Held
5.6M-
Black Rock Inc. New York, NY34.5MShares$2.62 Billion0.09% of portfolio
-
Capital Research Global Investors Los Angeles, CA17.9MShares$1.36 Billion0.26% of portfolio
-
State Street Corp Boston, MA16.7MShares$1.26 Billion0.05% of portfolio
-
Baillie Gifford & CO15MShares$1.14 Billion0.77% of portfolio
-
Sands Capital Management, LLC Arlington, VA10.3MShares$783 Million2.2% of portfolio
About DEXCOM INC
- Ticker DXCM
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 386,257,984
- Market Cap $29.3B
- Description
- DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...